Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7241
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction ; day:26 ; month:5 ; year:2020 ; pages:1-11
Cardiovascular drugs and therapy ; (26.5.2020), 1-11
- Urheber
-
Yurista, Salva R.
Silljé, Herman H. W.
Nijholt, Kirsten T.
Dokter, Martin M.
Veldhuisen, Dirk J. van
Boer, Rudolf A. de
Westenbrink, B. Daan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10557-020-06999-7
- URN
-
urn:nbn:de:101:1-2020073022103229338779
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yurista, Salva R.
- Silljé, Herman H. W.
- Nijholt, Kirsten T.
- Dokter, Martin M.
- Veldhuisen, Dirk J. van
- Boer, Rudolf A. de
- Westenbrink, B. Daan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis of Coagulation Factor Xa Inhibitor Apixaban
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Pharmakokinetik und Interaktionen von gemeinsam verabreichten mikrodosierten Faktor-Xa-Inhibitoren Rivaroxaban, Apixaban und Edoxaban
Apixaban plasma concentrations in patients with obesity
Molecular imaging of cardiac remodelling after myocardial infarction
Initial apixaban dosing in patients with atrial fibrillation
Apixaban prophylactic anticoagulation in patients with nephrotic syndrome.
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
Spontaneous splenic rupture associated with apixaban: a case report
Chronic Development of Ischaemic Mitral Regurgitation during Post-Infarction Remodelling
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Massive Intoxication with 70 Tablets of Apixaban: A Case Report
Synthesis of Coagulation Factor Xa Inhibitor Apixaban
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Pharmakokinetik und Interaktionen von gemeinsam verabreichten mikrodosierten Faktor-Xa-Inhibitoren Rivaroxaban, Apixaban und Edoxaban
Apixaban plasma concentrations in patients with obesity
Molecular imaging of cardiac remodelling after myocardial infarction
Initial apixaban dosing in patients with atrial fibrillation
Apixaban prophylactic anticoagulation in patients with nephrotic syndrome.
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
Spontaneous splenic rupture associated with apixaban: a case report
Chronic Development of Ischaemic Mitral Regurgitation during Post-Infarction Remodelling
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Massive Intoxication with 70 Tablets of Apixaban: A Case Report
Synthesis of Coagulation Factor Xa Inhibitor Apixaban
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Pharmakokinetik und Interaktionen von gemeinsam verabreichten mikrodosierten Faktor-Xa-Inhibitoren Rivaroxaban, Apixaban und Edoxaban
Apixaban plasma concentrations in patients with obesity
Molecular imaging of cardiac remodelling after myocardial infarction
Initial apixaban dosing in patients with atrial fibrillation
Apixaban prophylactic anticoagulation in patients with nephrotic syndrome.
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
Spontaneous splenic rupture associated with apixaban: a case report
Chronic Development of Ischaemic Mitral Regurgitation during Post-Infarction Remodelling
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series